Simon James, Author at Segra International
Segra International is a plant biotechnology company that specializes in industrial-scale cannabis plant micropropagation. The company is developing industrial-scale cannabis micropropagation laboratories to produce healthy, robust plantlets for licensed cannabis producers globally.
Segra, Cannabis Micropropagation, Cannabis Tissue Culture, Research and Development, R&D, Quality Management Systems, facilities, plant-based medicines, medicinal, Cannabis, botanical, tissue culture, specialist, Genotyping Services, Tissue Culture Production, Modular Growing Facility, Micropropagation
4
archive,author,author-simon,author-4,ajax_fade,page_not_loaded,,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

Author: Simon James

PRESS RELEASES

VANCOUVER, Mar. 27th, 2018 – Segra International Corp. (“Segra” or the “Company) is pleased to announce that its application to produce cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”), through its wholly-owned subsidiary Segra Biogenesis Corp., has progressed to “active review” status....